Meanwhile, MLN4924 can inhibit the NF-κB pathway activity in DLBCL cells, thereby inhibiting the proliferation of DLBCL cells (Godbersen et al., 2014). The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.